$33.72
0.13[0.39%]
At close: May 16
$33.72
0[0.00%]
After Hours: 4:00PM EDT
Neurogene
(NASDAQ:NGNE)Neurogene Stock (NASDAQ:NGNE), Quotes and News Summary
Neurogene Stock (NASDAQ: NGNE) stock price, news, charts, stock research, profile.
| Open | $33.590 |
| Close | $33.720 |
| Volume / Avg. | 57.033K / 136.278K |
| Day Range | 33.000 - 35.210 |
| 52 Wk Range | 12.490 - 53.000 |
| Market Cap | $437.695M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 48 |
| Short Interest | 8.76% |
| Days to Cover | 11.33 |
Recent News
No news found
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Neurogene (NGNE) stock?
You can purchase shares of Neurogene (NASDAQ: NGNE) through any online brokerage.
Who are Neurogene's (NGNE) competitors?
Other companies in Neurogene’s space includes: Voyager Therapeutics (NASDAQ:VYGR), PepGen (NASDAQ:PEPG), Replimune Group (NASDAQ:REPL), Fate Therapeutics (NASDAQ:FATE) and Anika Therapeutics (NASDAQ:ANIK).
What is the target price for Neurogene (NGNE) stock?
The latest price target for Neurogene (NASDAQ: NGNE) was reported by HC Wainwright & Co. on Monday, May 13, 2024. The analyst firm set a price target for 51.00 expecting NGNE to rise to within 12 months (a possible 51.25% upside). 10 analyst firms have reported ratings in the last year.
Current Stock Price for Neurogene (NGNE)?
The stock price for Neurogene (NASDAQ: NGNE) is $33.72 last updated Today at May 16, 2024 at 4:15 PM EDT.
Does Neurogene (NGNE) pay a dividend?
There are no upcoming dividends for Neurogene.
When is Neurogene (NASDAQ:NGNE) reporting earnings?
Neurogene’s Q2 earnings are confirmed for Thursday, August 15, 2024.
Is Neurogene (NGNE) going to split?
There is no upcoming split for Neurogene.
What sector and industry does Neurogene (NGNE) operate in?
Neurogene is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.